Unmesh Shrikant Jere
About Unmesh Shrikant Jere
Data last updated:
Unmesh Shrikant Jere is a Director at Octance Healthcare Private Limited (since 2025) and Director at Octance Lifesciences Private Limited (since 2026). The companies operate in Chemicals and Pharma. The largest current company by reported revenue is Octance Healthcare Private Limited at ₹1.19 Cr (FY 2024). Earlier, Unmesh Shrikant Jere was a Director at Manchester Lifesciences Private Limited (2019–2022) and Additional Director at Manchester Pharma Private Limited (2019–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Octance Healthcare Private Limited U24290MH2022PTC385039 | Director | 18 Aug 2025 | 2022 | ₹1.19 Cr (FY 2024) | Active |
| Octance Lifesciences Private Limited U21002MH2026PTC474319 | Director | 04 Aug 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Manchester Lifesciences Private Limited U24100MH2016PTC287765 | Director | 23 Dec 2019 | 2016 | ₹13.5 Lakh (FY 2022) | Active |
| Manchester Pharma Private Limited U74999MH2016PTC287047 | Additional Director | 12 Apr 2019 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Unmesh Shrikant Jere
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shweta Unmesh Jere | 09645981 | Octance Healthcare Private Limited , Octance Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Unmesh Shrikant Jere
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unmesh Shrikant Jere
Unmesh Shrikant Jere currently holds 2 directorships: Octance Healthcare Private Limited (Director, since 18 Aug 2025, revenue ₹1.19 Cr (FY 2024)); Octance Lifesciences Private Limited (Director, since 04 Aug 2026).
Unmesh Shrikant Jere was first appointed on 12 Apr 2019 as Additional Director at Manchester Pharma Private Limited. The most recent appointment on record is 04 Aug 2026 at Octance Lifesciences Private Limited.
Unmesh Shrikant Jere held 2 earlier board appointments: Manchester Lifesciences Private Limited (Director, 23 Dec 2019 to 11 Jan 2022); Manchester Pharma Private Limited (Additional Director, 12 Apr 2019 to 14 Jan 2020).
The current boards of Unmesh Shrikant Jere's companies include Shweta Unmesh Jere (Octance Healthcare Private Limited).